Travere Therapeutics Inc (TVTX)

Oct 10, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe

Oct 10, 2025

Oct 10, 2025

Will Travere Therapeutics Inc. price bounce be sustainableQuarterly Investment Review & Fast Moving Trade Plans - newser.com

Oct 10, 2025

Oct 10, 2025

What moving averages say about Travere Therapeutics Inc.Quarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Travere Therapeutics (NASDAQ:TVTX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Travere rises as FDA says no AdCom required for Filspari label expansion - MSN

Oct 09, 2025

Oct 09, 2025

Focal Segmental Glomerulosclerosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva Pharma - The Globe and Mail

Oct 09, 2025

Oct 09, 2025

How to recover losses in Travere Therapeutics Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com

Oct 09, 2025

Oct 08, 2025

Can Travere Therapeutics Sustain Its 48.9% Rally Amid Pipeline Progress in 2025? - Yahoo Finance

Oct 08, 2025

Oct 06, 2025

Can trapped investors hope for a rebound in Travere Therapeutics Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

What dividend safety score for Travere Therapeutics Inc. stockQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

What candlestick patterns are forming on Travere Therapeutics Inc.Market Activity Summary & Breakout Confirmation Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Will Travere Therapeutics Inc. stock deliver consistent dividendsMarket Activity Recap & Weekly Momentum Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Real time breakdown of Travere Therapeutics Inc. stock performanceJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Oct 05, 2025

Oct 04, 2025

Travere therapeutics CFO sells $104,463 in stock - MSN

Oct 04, 2025

Oct 03, 2025

Building trade automation scripts for Travere Therapeutics Inc.Bond Market & Real-Time Market Sentiment Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Heatmap analysis for Travere Therapeutics Inc. and competitors2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025

Oct 03, 2025

Why Travere Therapeutics Inc. (TVTX) Went Up On Tuesday? - MSN

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 01:41:47 - newser.com

Oct 03, 2025

Oct 01, 2025

Why Travere Therapeutics Inc. stock remains on watchlists2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com

Oct 01, 2025

Oct 01, 2025

Using data tools to time your Travere Therapeutics Inc. exit2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com

Oct 01, 2025

Sep 30, 2025

Travere Therapeutics stock rises on sNDA submission plans for FILSPARI - MSN

Sep 30, 2025

Sep 30, 2025

How to use a screener to detect Travere Therapeutics Inc. breakoutsGap Up & Risk Controlled Stock Alerts - newser.com

Sep 30, 2025

Sep 29, 2025

Travere Therapeutics (NASDAQ:TVTX) Trading Down 7.6%What's Next? - MarketBeat

Sep 29, 2025

Sep 29, 2025

Travere therapeutics CAO Calvin Sandra sells $17,520 in stock - MSN

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 13:53:58 - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 12:50:11 - newser.com

Sep 29, 2025

Sep 29, 2025

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Sep 29, 2025

Sep 28, 2025

Travere therapeutics CEO Eric M. Dube sells $273,455 in stock - MSN

Sep 28, 2025

Sep 28, 2025

Is GAIL India Limited One of the Top Picks for Growth Investors in YEARFlag and Pennant Patterns & Free Phenomenal Trading Returns - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Published on: 2025-09-28 13:45:23 - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Published on: 2025-09-28 02:30:57 - newser.com

Sep 28, 2025

Sep 28, 2025

Travere Therapeutics Inc Stock Analysis and ForecastMarket Profile Overview & Double Digit Returns - earlytimes.in

Sep 28, 2025

Sep 27, 2025

How FILSPARI’s Endorsement as First-Line Therapy Has Changed Travere Therapeutics’ (TVTX) Investment Story - Sahm

Sep 27, 2025

Sep 26, 2025

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy - Business Wire

Sep 26, 2025

Sep 26, 2025

Travere Therapeutics Forms Golden Cross, Signaling Bullish Breakout Ahead - Markets Mojo

Sep 26, 2025